Previous Article | Next Article ![]()
Applied and Environmental Microbiology, April 2008, p. 2153-2160, Vol. 74, No. 7
0099-2240/08/$08.00+0 doi:10.1128/AEM.02566-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
,
Mark E. Wickham,3,
,
Mariola Mascarenhas,2
Samantha Gruenheid,4
B. Brett Finlay,3 and
Mohamed A. Karmali2
Department of Biochemistry and Biomedical Sciences and Michael G. DeGroote Institute for Infectious Disease Research, McMaster University, Hamilton, Ontario, Canada,1 Laboratory for Foodborne Zoonoses, Public Health Agency of Canada, Guelph, Ontario, Canada,2 Michael Smith Laboratories, University of British Columbia, Vancouver, British Columbia, Canada,3 Department of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada4
Received 14 November 2007/ Accepted 21 January 2008
Shiga toxin-producing Escherichia coli (STEC) strains are commensal bacteria in cattle with high potential for environmental and zoonotic transmission to humans. Although O157:H7 is the most common STEC serotype, there is growing concern over the emergence of more than 200 highly virulent non-O157 STEC serotypes that are globally distributed, several of which are associated with outbreaks and/or severe human illness such as hemolytic-uremic syndrome (HUS) and hemorrhagic colitis. At present, the underlying genetic basis of virulence potential in non-O157 STEC is unknown, although horizontal gene transfer and the acquisition of new pathogenicity islands are an expected origin. We used seropathotype classification as a framework to identify genetic elements that distinguish non-O157 STEC strains posing a serious risk to humans from STEC strains that are not associated with severe and epidemic disease. We report the identification of three genomic islands encoding non-LEE effector (nle) genes and 14 individual nle genes in non-O157 STEC strains that correlate independently with outbreak and HUS potential in humans. The implications for transmissible zoonotic spread and public health are discussed. These results and methods offer a molecular risk assessment strategy to rapidly recognize and respond to non-O157 STEC strains from environmental and animal sources that might pose serious public health risks to humans.
Published ahead of print on 1 February 2008.
Supplemental material for this article may be found at http://aem.asm.org/.
B.K.C. and M.E.W. contributed equally to this study.
Present address: Phillips, Ormonde, and Fitzpatrick, Melbourne, Australia.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»